Extreme thrombocytosis in systemic juvenile idiopathic arthritis. A case report

Ital J Pediatr. 2019 Jun 24;45(1):73. doi: 10.1186/s13052-019-0664-4.

Abstract

Background: Systemic onset juvenile idiopathic arthritis (SoJIA) is a rare inflammatory disorder characterized by remitting fevers, evanescent rash, generalized lymphadenopathy, hepatomegaly/splenomegaly, and/or serositis.

Case presentation: Here we report the case of a 5 years-old girl with SoJIA complicated by severe thrombocytosis. Treatment with the Interleukin-1β (IL-1β) receptor antagonist Anakinra caused a fast reduction of blood platelets and of the associated systemic inflammatory response. Measurement of IL-1β, IL-6 and Tpo plasma levels at different time points confirmed the etiopathogenetic role of IL-1β in causing the thrombocytosis, while Tpo did not appear to be involved and this explains the excellent response to treatment with Anakinra.

Conclusion: The excellent response to treatment with the IL-1β receptor antagonist, suggests a key pathogenic role of IL-1β in thrombocytosis as well as in the associated systemic symptoms of inflammation.

Keywords: Case report; Systemic arthritis; Thrombocytosis.

Publication types

  • Case Reports

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Juvenile / complications*
  • Arthritis, Juvenile / drug therapy*
  • Child, Preschool
  • Cytokines / blood
  • Female
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*
  • Interleukin-1beta / antagonists & inhibitors
  • Thrombocytosis / drug therapy*
  • Thrombocytosis / etiology*

Substances

  • Antirheumatic Agents
  • Cytokines
  • IL1B protein, human
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1beta